| Financial Year |
March 31 2023 |
| Monetary Funds |
214,674,946.30 |
| Held-for-trading Financial Assets |
150,000,000.00 |
| Notes Receivable |
9,788,913.20 |
| Accounts Receivable |
377,839,812.31 |
| Advances to Suppliers |
22,668,263.78 |
| Other Receivables |
12,035,007.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
76,598,414.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
65,567,959.39 |
| Other Current Assets |
3,778,181.57 |
| Total Current Assets |
970,118,478.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
114,454,119.09 |
| Long-term Equity Investment |
52,683,797.16 |
| Investment Properties |
-- |
| Fixed Assetes |
86,362,120.26 |
| Under-construction Projects |
8,759,357.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
57,453,105.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
51,533,923.89 |
| Other Non-Current Assets |
53,148,502.05 |
| Sub-Total of Non-Current Assets |
458,743,634.94 |
| Total Assets |
1,428,862,113.70 |
| Short-Term Loans |
25,335,889.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
38,008,019.99 |
| Accounts Payable |
202,375,788.93 |
| Accounts Received In Advance |
20,541,078.16 |
| Employee Compensation Payable |
6,526,845.22 |
| Taxes Payable |
30,066,433.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,909,996.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
717,547.32 |
| Other Current Liabilities |
5,554,865.52 |
| Sub-Total of Current Liabilities |
365,502,922.22 |
| Long-term Loans |
-- |
| Bonds Payable |
203,509,872.63 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
205,790,072.52 |
| Total Liabilities |
571,292,994.74 |
| Paid-In Capital(Or Share Stock) |
163,177,886.00 |
| Capital Surplus |
369,480,449.68 |
| Surplus Reserve |
38,482,914.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
247,301,865.96 |
| Minority Stockholder's Interest |
5,609,460.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
851,959,658.81 |
| Owner's Equity（Stockholder's Equity） |
857,569,118.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,428,862,113.70 |
